These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 987962)

  • 1. [Effects of fusaric acid and its derivative on the cardiovascular system].
    Furuta Y; Washizaki M
    Nihon Yakurigaku Zasshi; 1976 Mar; 72(2):139-44. PubMed ID: 987962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tachycardia in spontaneously hypertensive and normotensive rats after fusaric acid and bupicamide.
    Antonaccio MJ; Coté D; Cavaliere T
    Clin Exp Pharmacol Physiol; 1976; 3(3):199-206. PubMed ID: 975616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxation of isolated rabbit arteries by fusaric (5-butylpicolinic) acid.
    Hidaka H; Asano M
    J Pharmacol Exp Ther; 1976 Dec; 199(3):620-9. PubMed ID: 994019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological studies of fusaric acid. II. (author's transl)].
    Matsuzaki M; Onodera K; Nakajima A; Kamei E; Koshino M
    Jpn J Antibiot; 1976 Apr; 29(4):419-29. PubMed ID: 819677
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contractile responses of mammalian cerebral arteries to 15-hydroperoxyarachidonic acid vary in the presence of fusaric acid and verapamil.
    Asano M; Matsuda T; Suzuki Y; Hidaka H
    Pharmacology; 1984; 28(5):251-61. PubMed ID: 6728899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of dopamine beta-hydroxylase in blood vessels by picolinic acid derivatives in vivo and their anthypertensive effects.
    Hidaka H; Shoka F; Hashizume Y; Takemoto N; Yamamoto M
    Jpn J Pharmacol; 1975 Oct; 25(5):515-24. PubMed ID: 1221134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of cerebrovascular CO2 reactivity by inhibition of dopamine beta-hydroxylase.
    Oishi M; Gotoh F; Toyoda M; Seki T; Takeoka T; Takagi S; Niimi T
    Stroke; 1979; 10(4):407-11. PubMed ID: 41344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure decreased by halobutylpicolinic acid, an inhibitor of dopamine beta-hydroxylase.
    Hidaka H; Takeya K
    Nature; 1972 Oct; 239(5371):334-5. PubMed ID: 12635227
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 14. The long-term hemodynamic effect of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Suzuki T
    Jpn Circ J; 1976 Sep; 40(9):1025-31. PubMed ID: 994314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of brovincamine and possible mechanisms involved.
    Kushiku K; Katsuragi T; Mori R; Morishita H; Furukawa T
    Clin Exp Pharmacol Physiol; 1985; 12(2):121-30. PubMed ID: 4006317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusaric acid derivatives and analogues as possible antihypertensive drugs. Note I.
    Runti C; de Nardo M; Ulian F
    Farmaco Sci; 1981 Apr; 36(4):260-8. PubMed ID: 7250360
    [No Abstract]   [Full Text] [Related]  

  • 18. [Toxicobiological properties of fusaric acid].
    Bilai VI; Cherkes OI; Bogomolova LO; Frantsuzova SB
    Mikrobiol Zh; 1975; 37(3):325-8. PubMed ID: 1214653
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
    Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T
    Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.